Vimarsana
Biggest News Aggregation in the World

Page 4 - Life Sciences Summit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Sciences Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Sciences Summit Today - Breaking & Trending Today

9 Meters Biopharma, Inc. to Participate in the Truist Securities 7th Annual Life Sciences Summit - Vimarsana News

9 Meters Biopharma, Inc. to Participate in the Truist Securities 7th Annual Life Sciences Summit

9 Meters Biopharma, Inc. to Participate in the Truist Securities 7th Annual Life Sciences Summit RALEIGH, NC / ACCESSWIRE / April 21, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, today announced that management will participate in the 7 th Annual Truist Securities Life Sciences Summit and invites investors to participate in one-on-one meetings. Please see additional details below: Truist Securities 7 Date: May 4 - 5, 2021 Participation: Management will be available for 1-on-1 meetings virtually Please contact your...

Investegate |INVENTIVA Announcements | INVENTIVA: Full-Year 2020: Cash position and revenues - Vimarsana News

Investegate |INVENTIVA Announcements | INVENTIVA: Full-Year 2020: Cash position and revenues

Important Notice This press release contains forward-looking statements, forecasts and estimates with respect to Inventiva’s clinical trials, clinical trial data releases, clinical development plans and anticipated future activities of Inventiva. Certain of these statements, forecasts and estimates can be recognized by the use of words such as, without limitation, “believes”, “anticipates”, “expects”, “intends”, “plans”, “seeks”, “estimates”, “may”, “will” and “continue” and similar expressions. Such statements are not historical facts but rather are ...

INVENTIVA: Full-Year 2020: Cash position and revenues - Vimarsana News

INVENTIVA: Full-Year 2020: Cash position and revenues

Cash position2 at €113.0m as of December 31, 2020 compared to €124.6 million at September 30, 2020 and €35.8 million at December 31, 2019Revenues of €0.4m in 2020 compared to €7.0m in 2019Successful €94.9m3